International Financial Reporting Standards

Xtract One Releases Second Quarter Fiscal 2024 Results

Retrieved on: 
Thursday, March 7, 2024

TORONTO, March 07, 2024 (GLOBE NEWSWIRE) -- Xtract One Technologies Inc. (TSX: XTRA) (OTCQX: XTRAF) (FRA: 0PL) (“Xtract One” or the “Company”), a leading technology-driven threat detection and security solution that prioritizes the patron access experience by leveraging AI, today announced fiscal second quarter results for the three and six month periods ended January 31, 2024.

Key Points: 
  • TORONTO, March 07, 2024 (GLOBE NEWSWIRE) -- Xtract One Technologies Inc. (TSX: XTRA) (OTCQX: XTRAF) (FRA: 0PL) (“Xtract One” or the “Company”), a leading technology-driven threat detection and security solution that prioritizes the patron access experience by leveraging AI, today announced fiscal second quarter results for the three and six month periods ended January 31, 2024.
  • Gross margin of 61.1% for the second quarter as compared to 47.1% for the same period last year.
  • While the fiscal second quarter is typically impacted by seasonal factors, we remain on track for record-setting performance, with strong results anticipated in the second half of the fiscal year.
  • Xtract One will host a conference call to discuss its results on Friday, March 8, 2024, at 10:00 am EST.

Profound Medical Announces Fourth Quarter and Full Year 2023 Financial Results

Retrieved on: 
Thursday, March 7, 2024

TORONTO, March 07, 2024 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets customizable, incision-free therapies for the ablation of diseased tissue, today reported financial results for the fourth quarter and full year ended December 31, 2023.

Key Points: 
  • TORONTO, March 07, 2024 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets customizable, incision-free therapies for the ablation of diseased tissue, today reported financial results for the fourth quarter and full year ended December 31, 2023.
  • Fourth quarter 2023 revenue increased 60% from approximately $1.3 million in the same three-month period a year ago.
  • G&A expenses for the 2023 fourth quarter increased by 41% to approximately $3.0 million, compared with approximately $2.1 million in the same period in 2022.
  • Fourth quarter 2023 S&D expenses increased by 74% to approximately $2.9 million, compared with $1.7 million in the fourth quarter of 2022.

AirBoss Reports 4th Quarter and Full Year 2023 Results

Retrieved on: 
Thursday, March 7, 2024

For the quarter and 2023, volume was down 17.5% with decreases across the majority of sectors given softness in many customer sectors.

Key Points: 
  • For the quarter and 2023, volume was down 17.5% with decreases across the majority of sectors given softness in many customer sectors.
  • Tolling volume was down 63.0% in the quarter and 59.6% in 2023, from the comparable periods in 2022.
  • Non-tolling volume was down 9.9% for the quarter and by 7.4% in 2023, compared to the same periods in 2022.
  • AirBoss now reports results under two segments: (1) AirBoss Rubber Solutions (“ARS”), and (2) AirBoss Manufactured Products (“AMP”).

Purple Biotech Reports Fourth Quarter and Full-Year 2023 Financial Results

Retrieved on: 
Tuesday, March 5, 2024

REHOVOT, Israel, March 05, 2024 (GLOBE NEWSWIRE) -- Purple Biotech Ltd. ("Purple Biotech" or "the Company") (NASDAQ/TASE: PPBT), a clinical-stage company developing first-in-class therapies that harness the power of the tumor microenvironment to overcome tumor immune evasion and drug resistance, today announced financial results for the fourth quarter and full year ended December 31, 2023.

Key Points: 
  • REHOVOT, Israel, March 05, 2024 (GLOBE NEWSWIRE) -- Purple Biotech Ltd. ("Purple Biotech" or "the Company") (NASDAQ/TASE: PPBT), a clinical-stage company developing first-in-class therapies that harness the power of the tumor microenvironment to overcome tumor immune evasion and drug resistance, today announced financial results for the fourth quarter and full year ended December 31, 2023.
  • At the American Association for Cancer Research (AACR) Special Conference on pancreatic cancer, Purple Biotech presented new potential PDAC biomarker data for CM24.
  • In February 2023, Purple Biotech acquired a platform of conditionally activated T cell and NK cell engagers that selectively activate immune response within the tumor microenvironment.
  • As of December 31, 2023, Purple Biotech had cash and cash equivalents and short-term deposits of $15.3 million, compared to $31.7 million on December 31, 2022.

Grupo Aeroportuario Del Pacifico Announces Annual General Ordinary And Extraordinary Shareholders’ Meeting

Retrieved on: 
Thursday, February 29, 2024

GUADALAJARA, Mexico, Feb. 29, 2024 (GLOBE NEWSWIRE) -- Grupo Aeroportuario del Pacífico, S.A.B.

Key Points: 
  • GUADALAJARA, Mexico, Feb. 29, 2024 (GLOBE NEWSWIRE) -- Grupo Aeroportuario del Pacífico, S.A.B.
  • de C.V. invites its shareholders to the General Ordinary and General Extraordinary Shareholders’ Meeting on April 25, 2024 at 12:00 and 2:00 pm, respectively, in Salon Midtown Ballroom 3, 3rd floor of the Hilton Hotel, located at Av.
  • V. Cancellation of any amounts outstanding under the share repurchase program approved at the Annual General Ordinary Shareholders’ Meeting that took place on April 13, 2023, which amounts to Ps.
  • The statements are based on many assumptions and factors, including general economic and market conditions, industry conditions, and operating factors.

Osisko Development Provides Update on Upcoming Year-End 2023 Results

Retrieved on: 
Wednesday, February 21, 2024

MONTREAL, Feb. 21, 2024 (GLOBE NEWSWIRE) -- Osisko Development Corp. (NYSE: ODV, TSXV: ODV) ("Osisko Development" or the "Company") announces that it has undertaken a review of the carrying value of its assets in accordance with International Financial Reporting Standards (the "Impairment Analysis") as at December 31, 2023, as part of its fourth quarter and year-end 2023 financial results preparation.

Key Points: 
  • MONTREAL, Feb. 21, 2024 (GLOBE NEWSWIRE) -- Osisko Development Corp. (NYSE: ODV, TSXV: ODV) ("Osisko Development" or the "Company") announces that it has undertaken a review of the carrying value of its assets in accordance with International Financial Reporting Standards (the "Impairment Analysis") as at December 31, 2023, as part of its fourth quarter and year-end 2023 financial results preparation.
  • The asset impairment charge will be a non-cash item and, for the avoidance of doubt, will have no impact on Company cash flows.
  • The Impairment Analysis will be finalized and recognized in the Company's consolidated financial statements for the year ended December 31, 2023.
  • The Company anticipates releasing a new mineral resource estimate ("MRE") for the Trixie deposit in March 2024, and its fourth quarter and year-end 2023 operating and financial results at the end of March 2024.

Hunting PLC (“Hunting” or “the Company” or “the Group”) Results for the year ended 31 December 2023

Retrieved on: 
Thursday, February 29, 2024

The global outlook for energy in the year ahead will be driven by similar themes to those reported in 2023.

Key Points: 
  • The global outlook for energy in the year ahead will be driven by similar themes to those reported in 2023.
  • The Middle East will also likely show a continuation of the activity levels reported in 2023.
  • The Enpro business should also support this growth profile given the orders secured in the second half of 2023.
  • For access to the Financial Statements and Notes to the Accounts for the year ended 31 December 2023 please click on the following link.

VTEX Reports Fourth Quarter 2023 Financial Results

Retrieved on: 
Tuesday, February 27, 2024

VTEX (NYSE: VTEX), the global enterprise digital commerce platform, today announced results for the fourth quarter of 2023 ended December 31, 2023.

Key Points: 
  • VTEX (NYSE: VTEX), the global enterprise digital commerce platform, today announced results for the fourth quarter of 2023 ended December 31, 2023.
  • Geraldo Thomaz Jr., founder and co-CEO of VTEX, commented, “In 2023, we consistently surpassed expectations quarter after quarter, navigating an uncertain economic landscape.
  • Non-GAAP subscription gross margin was 78.6% in the fourth quarter of 2023, compared to 73.5% in the same quarter of 2022.
  • Non-GAAP income from operations was US$11.6 million during the fourth quarter of 2023, compared to a Non-GAAP income from operations of US$1.7 million in the third quarter of 2023 and a Non-GAAP income from operations of US$2.1 million in the same quarter of 2022.

Nu Holdings Ltd. Reports Fourth Quarter and Full Year 2023 Financial Results

Retrieved on: 
Thursday, February 22, 2024

Nu Holdings Ltd. (NYSE: NU), (“Nu” or the “Company”), one of the world’s largest digital financial services platforms, released today its Fourth Quarter and Full Year 2023 financial results.

Key Points: 
  • Nu Holdings Ltd. (NYSE: NU), (“Nu” or the “Company”), one of the world’s largest digital financial services platforms, released today its Fourth Quarter and Full Year 2023 financial results.
  • Financial results are expressed in U.S. dollars and are presented in accordance with International Financial Reporting Standards (IFRS).
  • In Brazil, the customer base reached 87.8 million by December 31, 2023, representing 53% of the country’s adult population.
  • Nu is the fourth-largest financial institution by number of customers in the country, according to Brazilian Central Bank data.

Corporación Inmobiliaria Vesta Reports Fourth Quarter 2023 Earnings Results

Retrieved on: 
Thursday, February 22, 2024

de C.V., (“Vesta”, or the “Company”) (BMV: VESTA; NYSE: VTMX), a leading industrial real estate company in Mexico, today announced results for the fourth quarter ended December 31, 2023.

Key Points: 
  • de C.V., (“Vesta”, or the “Company”) (BMV: VESTA; NYSE: VTMX), a leading industrial real estate company in Mexico, today announced results for the fourth quarter ended December 31, 2023.
  • Vesta delivered outstanding financial results for the full year 2023, achieving US$ 214.5 million in total income; a 20.5% year over year increase exceeding the upper range of its 19-20% revenue guidance for the full year 2023.
  • Vesta’s fourth quarter 2023 total portfolio occupancy reached 93.4%, while stabilized and same-store occupancy reached 96.7% and 97.0%, respectively.
  • During the fourth quarter, Vesta sold 8.5 hectares of land in Aguascalientes for US$ 5.1 million.